PFAI · Pinnacle Food Group Limited Class A Common Shares

This announcement represents a HIGH-materiality technical milestone with direct implications for Pinnacle Food Group Limited’s commercial trajectory and competitive positioning. The methanol-free fermentation platform addresses two major industry constraints: safety risk and cost inefficiency inherent in traditional methanol-dependent Pichia systems. By eliminating methanol—a highly flammable, toxic solvent—the Company mitigates severe fire hazards and avoids the massive capital expenditure required for explosion-proof infrastructure, thereby lowering barriers to scale. The zero-toxic-residue outcome is not merely incremental; it satisfies stringent purity requirements for regulated end markets, particularly infant nutrition and pharmaceuticals, where contamination risks carry significant regulatory and reputational consequences. Critically, the platform’s validation with 'other protein targets' at pilot scale confirms its modularity and de-risks future product expansion beyond rhLF. While rhLF itself serves high-margin, growing segments—especially as demand rises for bioengineered human milk proteins—the broader strategic value lies in the platform’s transferability. As stated by CEO Jiulong You, this breakthrough validates the Company’s precision fermentation capabilities and accelerates its path toward becoming a B2B supplier of high-value biological ingredients. For investors, this signals tangible progress on the 'bio-engineering engine' of the Dual-Engine strategy and strengthens the foundation for near-term revenue diversification and long-term margin expansion through proprietary, scalable manufacturing.